Acclaro Medical proudly announces new clinical study results on nasal contouring, acne scarring, facial resurfacing, facial and neck rejuvenation with stem cell extract and UltraClear® Laser-Coring™ will be presented at the American Society for Laser Medicine and Surgery (ASLMS) global conference, to be held April 11-14, 2024 in Baltimore, MD.
UltraClear Laser is acclaimed by aesthetic laser specialists as a game-changer in combating the signs of aging and the effects of gravity with its unrivaled cosmetic results accompanied by patient comfort, rapid healing and superb safety across all skin tones, including skin of color and tanned skin.
Leading authorities in energy-based devices will demonstrate the versatility and advanced optics and laser pulse delivery of Acclaro's UltraClear 2910 nm fiber laser, alongside an in-depth review of Laser-Coring™ at Tech Connect and at the UltraClear Learning Lab 4 on Friday, April 12th and Saturday, April 13th, respectively.
"We are thrilled that UltraClear laser is taking center stage with its latest clinical study data, outstanding outcomes and innovative Laser-Coring™ techniques at this year's ASLMS meeting," said Shlomo Assa, MSc, Acclaro Medical's President and Chief Technology Officer. "Our strong presence exemplifies the bold trajectory and compelling value that UltraClear brings to the future of aesthetic laser skin solutions."
In addition to the scientific presentations, the company will also sponsor educational events focused on these and other UltraClear laser applications. Acclaro Medical activities at ASLMS:
For more information, please visit http://www.ultraclearlaser.com/
